+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nucleic Acid Nanotechnology Market by Application (Bioimaging, Biosensing, Diagnostics), Technology (Aptamer Nanostructures, DNA Origami, DNA Tiles), Product Type, End User - Global Forecast 2025-2030- Product Image
Nucleic Acid Nanotechnology Market by Application (Bioimaging, Biosensing, Diagnostics), Technology (Aptamer Nanostructures, DNA Origami, DNA Tiles), Product Type, End User - Global Forecast 2025-2030- Product Image
New

Nucleic Acid Nanotechnology Market by Application (Bioimaging, Biosensing, Diagnostics), Technology (Aptamer Nanostructures, DNA Origami, DNA Tiles), Product Type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6131573
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Nucleic acid nanotechnology has rapidly evolved from a conceptual framework into a vibrant field that bridges molecular biology, materials science, and engineering. At its core lies the ability to harness the predictable base-pairing properties of DNA and RNA to construct precise, programmable nanostructures. These architectures range from simple junctions and tiles to complex three-dimensional arrangements, all designed to execute functions at the nanoscale. As research methodologies have grown in sophistication, the potential to control molecular interactions with unprecedented accuracy has opened new horizons in diagnostics, therapeutics, and beyond.

The introduction of DNA origami in the mid-2000s marked a pivotal moment in the field, demonstrating that long single-stranded molecules could be folded into intricate shapes guided by staple strands. Since then, iterative innovations have expanded the toolkit to include aptamer-based assemblies, dynamic nanodevices capable of environmental responsiveness, and hybrid materials that integrate nucleic acids with proteins or inorganic nanoparticles. These advances have been driven by improved synthesis techniques, enhanced imaging modalities, and computational platforms that facilitate design and optimization. Consequently, nucleic acid nanotechnology now stands at the threshold of transforming both fundamental research and real-world applications.

Analyzing the Transformative Shifts in Nucleic Acid Nanotechnology That Are Redefining Research Paradigms and Enabling Breakthrough Applications Across Sectors

Recent years have witnessed transformative shifts in the nucleic acid nanotechnology landscape, propelled by both technological breakthroughs and interdisciplinary collaboration. Advancements in high-resolution imaging, such as cryo-electron microscopy paired with machine learning algorithms, now enable visualization of nanoscale assemblies in near-atomic detail. These capabilities have accelerated the rational design of scaffolds and dynamic systems, fostering an era in which bespoke structures are created with precision and reliability.

In addition, the integration of chemical modifications and responsive elements has endowed nucleic acid constructs with novel functionalities. Light-activated switches, pH-sensitive linkages, and enzyme-cleavable motifs have been seamlessly incorporated, allowing nanodevices to perform controlled actions in complex biological environments. Meanwhile, the convergence of synthetic biology and nucleic acid engineering has given rise to hybrid platforms that combine genetic circuits with structural frameworks, paving the way for programmable therapeutics and biosensing networks. Collectively, these shifts have redefined research paradigms by enabling applications that were once considered theoretical, and they continue to unlock new frontiers across healthcare, environmental monitoring, and materials science.

Assessing the Complex Cumulative Impact of United States Tariffs Implemented in 2025 on Supply Chains and Innovation Dynamics in Nucleic Acid Nanotechnology

The introduction of United States tariffs in early 2025 has exerted a multifaceted influence on supply chains and innovation dynamics within the nucleic acid nanotechnology sector. Raw materials, including specialized oligonucleotides and modified nucleotides, experienced cost escalations that reverberated through procurement processes. As a result, manufacturers and research institutions alike have confronted increased lead times and elevated budgets for critical reagents and custom synthesis services.

Consequently, stakeholders have sought to diversify their supplier networks and explore regional sourcing alternatives to mitigate exposure to tariff-related volatility. Domestic production capabilities have received renewed attention, prompting collaborations between academic laboratories and contract manufacturers to develop localized manufacturing hubs. This pivot has fostered resilience, yet it has also introduced complexities related to regulatory alignment and quality standardization. Moreover, the tariff landscape has encouraged companies to reevaluate their supply chain models, balancing cost pressures against the imperative to maintain robust pipelines for innovation. In the aggregate, the cumulative impact is shaping strategic decisions on inventory management, partnership selection, and long-term investment in manufacturing infrastructure.

Unveiling Key Segmentation Insights That Illuminate How Applications, Technologies, Product Types, and End Users Shape the Nucleic Acid Nanotechnology Market

A nuanced examination of market segmentation reveals how diverse drivers and end-user demands shape the nucleic acid nanotechnology ecosystem. From an application standpoint, the domain encompasses bioimaging techniques that exploit precise nanoarchitectures for enhanced resolution, biosensing platforms differentiated by electrochemical and fluorescent detection modalities, and diagnostic assays that leverage programmable probes for specificity. Therapeutic delivery strategies include both controlled release formulations and targeted delivery systems designed to navigate biological barriers, while tissue engineering applications harness scaffolded nucleic acid frameworks to guide cellular growth patterns.

Delving further, the technology landscape is characterized by aptamer nanostructures that provide high-affinity molecular recognition, DNA origami constructs engineered in two-dimensional sheets, three-dimensional objects, or scaffold-supported architectures, and nanoribbon and nanotube geometries available in single-wall or multi-wall configurations. Product offerings span precision instruments including AFM systems and electron microscopes for structural characterization, comprehensive kits and reagents for synthesis and assembly, as well as specialized services for design optimization and functional validation. Finally, end users range from government research laboratories and universities within academic and research institutes, to contract research organizations, diagnostic laboratories, and pharmaceutical and biotechnology companies. Each segment exhibits distinct adoption drivers, research priorities, and growth trajectories that collectively define the field’s evolution.

Mapping Critical Regional Dynamics in Nucleic Acid Nanotechnology to Highlight How Americas, Europe Middle East Africa, and Asia Pacific Drive Innovation

Regional dynamics play a pivotal role in the evolution of nucleic acid nanotechnology, with each geography exhibiting unique strengths and opportunities. In the Americas, robust academic ecosystems and a high concentration of biotechnology firms drive rapid translation of research into commercial ventures. These markets benefit from well-established infrastructure, venture capital investment, and a regulatory framework that, while stringent, offers clear pathways for clinical validation and product approval.

Across Europe, the Middle East, and Africa, collaborative networks among universities, government initiatives, and private enterprises are fostering innovation hubs focused on diagnostic and therapeutic applications. Regulatory harmonization efforts within the European Union support cross-border partnerships, while emerging markets in the Middle East are investing in research centers to cultivate homegrown expertise. In select African countries, nascent programs aim to address public health challenges through point-of-care biosensing and low-cost diagnostic solutions.

Asia-Pacific stands out for its large-scale manufacturing capabilities, government-backed research funding, and strategic collaborations among industry leaders in Japan, China, South Korea, and India. This region’s emphasis on integrating digital technologies with molecular platforms accelerates the deployment of smart sensing devices and personalized medicine approaches. Cumulatively, these regional footprints underscore the importance of localized strategies that capitalize on distinct strengths while fostering global cooperation.

Highlighting Prominent Companies Leading the Charge in Nucleic Acid Nanotechnology Through Strategic Initiatives Collaborations and Pioneering Developments

Leading organizations in nucleic acid nanotechnology are shaping the industry through strategic partnerships, advanced product pipelines, and targeted investments. Established multinational corporations have leveraged their scale to integrate high-throughput synthesis capabilities with advanced imaging and analytical platforms. At the same time, innovative startups and spinouts from academic institutions are pioneering novel design algorithms, responsive nanodevices, and hybrid material constructs that push the boundaries of functional performance.

Collaborative consortia have emerged as catalysts for cross-disciplinary synergies, bringing together experts in synthetic biology, materials science, and bioinformatics. Through joint ventures and co-development agreements, companies are expediting the translation of laboratory breakthroughs into commercially viable solutions. Furthermore, mergers and acquisitions continue to consolidate intellectual property portfolios and streamline access to specialized technologies. Collectively, these developments underscore a competitive landscape in which both scale and agility are essential for maintaining a leadership position in research, product development, and market penetration.

Formulating Actionable Strategic Recommendations for Industry Leaders to Capitalize on Emerging Trends and Navigate Challenges in Nucleic Acid Nanotechnology

Industry leaders seeking to capitalize on the momentum of nucleic acid nanotechnology should prioritize supply chain resilience, research agility, and strategic collaboration. By cultivating modular design platforms and open innovation frameworks, organizations can accelerate iterative testing and reduce time to proof of concept. Equally important is the establishment of diversified procurement strategies, including partnerships with regional manufacturers, to minimize the downstream effects of geopolitical shifts and trade policies.

Moreover, decision makers should invest in standardized protocols and digital infrastructure that facilitate reproducibility and data-driven optimization. Interdisciplinary training programs and ecosystem alliances can enhance the skill sets required to implement advanced assembly techniques and multiscale characterization methods. In parallel, embracing regulatory harmonization initiatives will streamline clinical translation pathways, while proactive intellectual property management will safeguard proprietary advances. Through these concerted actions, companies can not only navigate current challenges but also lay the groundwork for sustained innovation and market leadership.

Detailing a Rigorous Research Methodology to Demonstrate the Comprehensive Data Collection Analytical Approaches and Validation Techniques Employed

This report’s methodology integrates both qualitative and quantitative approaches to ensure a robust understanding of the nucleic acid nanotechnology landscape. Primary research involved in-depth interviews with leading scientists, corporate executives, and regulatory experts to capture real-time perspectives on innovation drivers and market barriers. Secondary research encompassed a comprehensive review of peer-reviewed publications, patent filings, conference proceedings, and technology whitepapers to trace historical developments and emerging trends.

Data analysis included thematic synthesis of expert insights, network mapping of collaborative partnerships, and comparative evaluation of material characterization techniques. Triangulation across multiple information sources was employed to validate findings and mitigate bias. Additionally, a dedicated advisory board provided iterative feedback on interim results, enhancing the report’s accuracy and relevance. This rigorous methodology underpins the report’s strategic conclusions and offers stakeholders a transparent framework for understanding the evidence base supporting each insight.

Concluding Insights That Synthesize Major Findings and Emphasize the Strategic Implications for Stakeholders in the Nucleic Acid Nanotechnology Landscape

In summation, nucleic acid nanotechnology stands as a highly dynamic field driven by scientific ingenuity, technological breakthroughs, and evolving market demands. The intricate interplay of application-specific requirements, material innovations, regulatory environments, and regional strengths underscores the necessity of a holistic perspective. Insights derived from segmentation analysis, tariff impact assessments, and competitive landscapes highlight both the opportunities for growth and the challenges to be addressed.

For stakeholders, the imperative is clear: embrace strategic flexibility, foster cross-sector collaboration, and invest in platforms that balance precision with scalability. Whether advancing diagnostic assays, developing therapeutic delivery vehicles, or engineering functional materials, the future success of nucleic acid nanotechnology will hinge on the ability to integrate multidisciplinary capabilities and adapt to a shifting global context. This executive summary has outlined the critical dimensions shaping the field, setting the stage for informed decision making and strategic action.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Bioimaging
    • Biosensing
      • Electrochemical Sensors
      • Fluorescent Sensors
    • Diagnostics
    • Drug Delivery
      • Controlled Release
      • Targeted Delivery
    • Therapeutics
    • Tissue Engineering
  • Technology
    • Aptamer Nanostructures
    • DNA Origami
      • 2D Origami
      • 3D Origami
      • Scaffold Structures
    • DNA Tiles
    • Nanoribbons
    • Nanotubes
      • Multi Wall
      • Single Wall
  • Product Type
    • Instruments
      • AFM Instruments
      • Electron Microscopes
    • Kits & Reagents
    • Services
  • End User
    • Academic & Research Institutes
      • Government Research Labs
      • Universities
    • Contract Research Organizations
    • Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Integrated DNA Technologies, Inc.
  • Twist Bioscience Corporation
  • GenScript Biotech Corporation
  • Eurofins Scientific SE
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Engineered DNA origami nanorobots enabling targeted cancer therapy with controllable drug release kinetics
5.2. Aptamer functionalized nucleic acid nanoparticles optimizing in vivo immunomodulation for autoimmune treatments
5.3. Lipid coated RNA origami frameworks enhancing mRNA vaccine stability and cellular uptake in clinical studies
5.4. CRISPR based nanostructure delivery platforms achieving single cell genome editing through endosomal escape strategies
5.5. siRNA loaded DNA tetrahedron carriers crossing the blood brain barrier in neurodegenerative disease preclinical trials
5.6. Commercial manufacturing scale up of nucleic acid nanodevices addressing regulatory challenges for diagnostic applications
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Nucleic Acid Nanotechnology Market, by Application
8.1. Introduction
8.2. Bioimaging
8.3. Biosensing
8.3.1. Electrochemical Sensors
8.3.2. Fluorescent Sensors
8.4. Diagnostics
8.5. Drug Delivery
8.5.1. Controlled Release
8.5.2. Targeted Delivery
8.6. Therapeutics
8.7. Tissue Engineering
9. Nucleic Acid Nanotechnology Market, by Technology
9.1. Introduction
9.2. Aptamer Nanostructures
9.3. DNA Origami
9.3.1. 2D Origami
9.3.2. 3D Origami
9.3.3. Scaffold Structures
9.4. DNA Tiles
9.5. Nanoribbons
9.6. Nanotubes
9.6.1. Multi Wall
9.6.2. Single Wall
10. Nucleic Acid Nanotechnology Market, by Product Type
10.1. Introduction
10.2. Instruments
10.2.1. AFM Instruments
10.2.2. Electron Microscopes
10.3. Kits & Reagents
10.4. Services
11. Nucleic Acid Nanotechnology Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.2.1. Government Research Labs
11.2.2. Universities
11.3. Contract Research Organizations
11.4. Diagnostic Laboratories
11.5. Pharmaceutical & Biotechnology Companies
12. Americas Nucleic Acid Nanotechnology Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Nucleic Acid Nanotechnology Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Nucleic Acid Nanotechnology Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Merck KGaA
15.3.3. Integrated DNA Technologies, Inc.
15.3.4. Twist Bioscience Corporation
15.3.5. GenScript Biotech Corporation
15.3.6. Eurofins Scientific SE
15.3.7. Agilent Technologies, Inc.
15.3.8. Danaher Corporation
15.3.9. Bio-Rad Laboratories, Inc.
15.3.10. QIAGEN N.V.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NUCLEIC ACID NANOTECHNOLOGY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NUCLEIC ACID NANOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NUCLEIC ACID NANOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NUCLEIC ACID NANOTECHNOLOGY MARKET: RESEARCHAI
FIGURE 24. NUCLEIC ACID NANOTECHNOLOGY MARKET: RESEARCHSTATISTICS
FIGURE 25. NUCLEIC ACID NANOTECHNOLOGY MARKET: RESEARCHCONTACTS
FIGURE 26. NUCLEIC ACID NANOTECHNOLOGY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NUCLEIC ACID NANOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOIMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOIMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY FLUORESCENT SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY FLUORESCENT SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APTAMER NANOSTRUCTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APTAMER NANOSTRUCTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY 2D ORIGAMI, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY 2D ORIGAMI, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY 3D ORIGAMI, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY 3D ORIGAMI, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY SCAFFOLD STRUCTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY SCAFFOLD STRUCTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA TILES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA TILES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANORIBBONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANORIBBONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY MULTI WALL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY MULTI WALL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY SINGLE WALL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY SINGLE WALL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY AFM INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY AFM INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ELECTRON MICROSCOPES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ELECTRON MICROSCOPES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY GOVERNMENT RESEARCH LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY GOVERNMENT RESEARCH LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 135. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2018-2024 (USD MILLION)
TABLE 138. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2025-2030 (USD MILLION)
TABLE 139. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 140. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 141. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 144. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 145. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2018-2024 (USD MILLION)
TABLE 146. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2025-2030 (USD MILLION)
TABLE 147. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 150. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 151. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 154. CANADA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 155. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2018-2024 (USD MILLION)
TABLE 158. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2025-2030 (USD MILLION)
TABLE 159. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 164. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 165. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2018-2024 (USD MILLION)
TABLE 166. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2025-2030 (USD MILLION)
TABLE 167. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 174. MEXICO NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 257. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2018-2024 (USD MILLION)
TABLE 260. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2025-2030 (USD MILLION)
TABLE 261. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 262. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 263. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 266. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 267. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2018-2024 (USD MILLION)
TABLE 268. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2025-2030 (USD MILLION)
TABLE 269. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 276. GERMANY NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 277. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2018-2024 (USD MILLION)
TABLE 280. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2025-2030 (USD MILLION)
TABLE 281. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 282. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 283. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 286. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 287. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2018-2024 (USD MILLION)
TABLE 288. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2025-2030 (USD MILLION)
TABLE 289. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 292. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 293. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 296. FRANCE NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY BIOSENSING, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY NANOTUBES, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA NUCLEIC ACID NANOTECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 201

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Nucleic Acid Nanotechnology market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Integrated DNA Technologies, Inc.
  • Twist Bioscience Corporation
  • GenScript Biotech Corporation
  • Eurofins Scientific SE
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.

Related Topics

Related Reports

DNA Nanotechnology for Cell Research. From Bioanalysis to Biomedicine. Edition No. 1 - Product Image

DNA Nanotechnology for Cell Research. From Bioanalysis to Biomedicine. Edition No. 1

  • Book
  • 544 Pages
Nucleic Acid Nanostructures Market by Structure Type (Dna Nanoribbons and Nanowires, Dna Origami, Dna Tiles and Lattices), Application (Biosensing and Diagnostics, Drug Delivery, Nanorobotics), End User, Material Type, Synthesis Approach - Global Forecast 2025-2030 - Product Image

Nucleic Acid Nanostructures Market by Structure Type (Dna Nanoribbons and Nanowires, Dna Origami, Dna Tiles and Lattices), Application (Biosensing and Diagnostics, Drug Delivery, Nanorobotics), End User, Material Type, Synthesis Approach - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Nucleic Acid-Based Nanomaterials. Stabilities and Applications. Edition No. 1 - Product Image

Nucleic Acid-Based Nanomaterials. Stabilities and Applications. Edition No. 1

  • Book
  • 224 Pages
Lipid-based Nanoparticles for the Pharmaceutical Industry: Pre-clinical and Clinical Advancements - Product Image

Lipid-based Nanoparticles for the Pharmaceutical Industry: Pre-clinical and Clinical Advancements

  • Report
  • 64 Pages
  • Global
From
Lipid Nanoparticles Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Lipid Nanoparticles Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.